Bjerregaard-Andersen, Kaare http://orcid.org/0000-0003-3609-3408
Johannesen, Hedda
Abdel-Rahman, Noha
Heggelund, Julie Elisabeth http://orcid.org/0000-0001-7805-1754
Hoås, Helene Mykland
Abraha, Fana
Bousquet, Paula A.
Høydahl, Lene Støkken
Burschowsky, Daniel
Rojas, Gertrudis
Oscarson, Stefan
Løset, Geir Åge http://orcid.org/0000-0002-5257-8571
Krengel, Ute http://orcid.org/0000-0001-6688-8151
Funding for this research was provided by:
Norges Forskningsråd (247730, 247730, 247730, 247730)
Science Foundation Ireland (08/SRC/B1393, 13/IA/1959, 08/SRC/B1393, 13/IA/1959)
Article History
Received: 10 April 2018
Accepted: 28 June 2018
First Online: 18 July 2018
Competing Interests
: G.R. works at the Center of Molecular Immunology, Havana, Cuba, which develops antibodies such as 14F7 for cancer immunotherapies. G.-Å. Løset works at the drug discovery company Nextera AS.